Skip to main content
. 2022 Dec;33(12):2211–2231. doi: 10.1681/ASN.2022030286

Figure 8.

Figure 8.

TEMRA CD8 T cells from KTs exhibit enhanced purinergic P2 × 4 receptor–dependent proinflammatory and migratory responses. The potential therapeutic targets to control the migration of CD8 T cells are shown in red. ABMR, antibody mediated rejection; WORT, wortmannin; CCCP, carbonyl cyanide m-chlorophenyl hydrazone.